These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2809743)

  • 1. Automated quantitation of three-dimensional cardiac positron emission tomography for routine clinical use.
    Hicks K; Ganti G; Mullani N; Gould KL
    J Nucl Med; 1989 Nov; 30(11):1787-97. PubMed ID: 2809743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myocardial positron computed tomography using N-13 ammonia for evaluating coronary artery disease: comparison with thallium-201 emission computed tomography].
    Tamaki N; Yonekura Y; Kodama S; Senda M; Saji H; Torizuka K; Kambara H; Kawai C; Konishi Y; Ban T
    J Cardiogr; 1985 Sep; 15(3):553-65. PubMed ID: 3879760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis of clinical positron emission tomography of the heart with rubidium-82.
    Gould KL; Goldstein RA; Mullani NA
    J Nucl Med; 1989 May; 30(5):707-17. PubMed ID: 2785587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpolating scan and oblique-angle tomograms in myocardial PET using nitrogen-13 ammonia.
    Senda M; Yonekura Y; Tamaki N; Saji H; Koide H; Nohara R; Kambara H; Konishi Y; Torizuka K
    J Nucl Med; 1986 Dec; 27(12):1830-6. PubMed ID: 3491190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future directions for clinical investigation of the heart with positron-emission tomography.
    Selwyn AP; Smith TW
    Circulation; 1985 Nov; 72(5 Pt 2):IV31-8. PubMed ID: 3876892
    [No Abstract]   [Full Text] [Related]  

  • 6. [Three-dimensional display and its quantification of exercise stress myocardial tomography using thallium-201].
    Narita M; Kurihara T; Murano K
    J Cardiol; 1992; 22(2-3):307-18. PubMed ID: 1339789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium].
    Haubold-Reuter B; Haldemann R; Amann F; Turina J; Reist W; Leenders K; von Schulthess GK
    Schweiz Med Wochenschr; 1992 Jan; 122(1-2):14-21. PubMed ID: 1594901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron imaging of myocardial infarction with rubidium-82.
    Goldstein RA; Mullani NA; Wong WH; Hartz RK; Hicks CH; Fuentes F; Smalling RW; Gould KL
    J Nucl Med; 1986 Dec; 27(12):1824-9. PubMed ID: 3491189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical cardiac positron emission tomography: state of the art.
    Gould KL
    Circulation; 1991 Sep; 84(3 Suppl):I22-36. PubMed ID: 1884490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of serial changes in absolute myocardial perfusion with 82Rb PET.
    deKemp RA; Ruddy TD; Hewitt T; Dalipaj MM; Beanlands RS
    J Nucl Med; 2000 Aug; 41(8):1426-35. PubMed ID: 10945537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET.
    Gould KL; Yoshida K; Hess MJ; Haynie M; Mullani N; Smalling RW
    J Nucl Med; 1991 Jan; 32(1):1-9. PubMed ID: 1988610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial perfusion with rubidium-82: III. Theory relating severity of coronary stenosis to perfusion deficit.
    Mullani NA
    J Nucl Med; 1984 Nov; 25(11):1190-6. PubMed ID: 6333493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography in the diagnosis and management of coronary artery disease.
    Bratton NG
    J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images.
    Porenta G; Kuhle W; Czernin J; Ratib O; Brunken RC; Phelps ME; Schelbert HR
    J Nucl Med; 1992 Sep; 33(9):1628-36. PubMed ID: 1517836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of rotational thallium-201 myocardial tomography.
    Garcia EV; Van Train K; Maddahi J; Prigent F; Friedman J; Areeda J; Waxman A; Berman DS
    J Nucl Med; 1985 Jan; 26(1):17-26. PubMed ID: 3871228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ischemic myocardial injury evaluated using positron emission tomography in children with coronary artery disease: comparison with thallium-201 SPECT].
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Yonekura Y; Yamashita K; Konishi J; Ban T; Mikawa H
    J Cardiol; 1992; 22(1):21-6. PubMed ID: 1307567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability.
    Go RT; MacIntyre WJ; Saha GB; Cook SA; Neumann DR; Chen EQ; Underwood DA; Kaczur T
    Radiology; 1995 Jan; 194(1):151-5. PubMed ID: 7997543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of positron emission tomography in the heart. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel.
    JAMA; 1988 Apr 22-29; 259(16):2438-45. PubMed ID: 3280846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for extraction of quantitative data from volumetric dynamic cardiac positron emission tomography data.
    Huesman RH; Klein GJ; Reutter BW; Coxson PG; Botvinick EH; Budinger TF
    Cardiology; 1997; 88(1):54-61. PubMed ID: 8960627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.